Hamilton Thorne (Hamilton Thorne) Total Current Assets : $33.29 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Hamilton Thorne Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Hamilton Thorne's total current assets for the quarter that ended in Mar. 2024 was $33.29 Mil.

Hamilton Thorne Total Current Assets Historical Data

The historical data trend for Hamilton Thorne's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Total Current Assets Chart

Hamilton Thorne Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

23.38

33.81

33.52

37.35

34.67

Hamilton Thorne Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial															38.00	39.01	37.99	34.67	33.29

Hamilton Thorne Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Hamilton Thorne's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	9.735	+	8.358	+	14.443	+	2.138
	=	34.67

Hamilton Thorne's Total Current Assets for the quarter that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	7.505	+	9.579	+	13.43	+	2.775
	=	33.29

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Hamilton Thorne (OTCPK:HTLZF) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Hamilton Thorne's Liquidation Value for the quarter that ended in Mar. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	7.505	-	43.581	+	0.75 * 9.579	+	0.5 * 13.43
=	-22.18

Hamilton Thorne Total Current Assets Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamilton Thorne (Hamilton Thorne) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (OTCPK:HTLZF) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

0ZM:Germany HTL:Canada

Address

100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915

Website

https://www.hamiltonthorne.ltd

Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.

Hamilton Thorne (Hamilton Thorne) Headlines

From GuruFocus

Hamilton Thorne to Announce Q3 2018 Financial Results and Hold Conference Call on November 20, 2018

By GlobeNewswire GlobeNewswire • 11-13-2018

TSX Venture Exchange, Hamilton Thorne Ltd., View From The C-Suite

By PRNewswire • 08-21-2023

Hamilton Thorne Announces US$7.5 Million Line of Credit

By GlobeNewswire GlobeNewswire • 09-30-2019

Hamilton Thorne to Announce Q3 2019 Financial Results and Hold Conference Call on November 21, 2019

By GlobeNewswire GlobeNewswire • 11-14-2019

Hamilton Thorne Ltd. Opens the Market

By PRNewswire • 09-21-2023

Hamilton Thorne to Announce Q1 2018 Financial Results and Hold Conference Call on May 24, 2018

By GlobeNewswire GlobeNewswire • 05-18-2018

Hamilton Thorne Equity Grants Under Its Long-Term Equity Incentive Plan

By GlobeNewswire GlobeNewswire • 10-13-2021